Prot# CCOX189A2367: A 13-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Trial of Lumiracoxib (COX189) 100mg o.d. in Patients with Primary Hip Osteoarthritis Using Celecoxib (200mg o.d.) as a Positive Control

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/04 → 3/31/07

Funding

  • Novartis Pharmaceuticals Corporation (CCOX189A2367)